Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Vascular dementia is the second-most common form of dementia after Alzheimer’s. About 2.7 million people in the U.S. are ...

Diabetes and weight loss drug semaglutide has been trialled in people with Alzheimer's. We explain what it means for dementia ...

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and protection from dementia may soon be added to the list. "But whether ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of ...

A large study suggests that semaglutide may not slow early Alzheimer’s symptoms, though researchers say important clues ...

(CN) — An analysis of nearly 1.7 million patient records suggests that semaglutide — the active ingredient in popular diabetes and weight loss medications like Ozempic and Wegovy — may significantly ...

There are several risk factors for dementia, including type 2 diabetes and obesity. A new study reports that semaglutide — the active ingredient in GLP-1 medications Ozempic and Wegovy for type 2 ...